Cargando…
Cross-cultural development of an EORTC questionnaire to assess health-related quality of life in patients with testicular cancer: the EORTC QLQ-TC26
OBJECTIVE: Testicular cancer (TC) is the most common cancer in young men, and its incidence is increasing. The low mortality rate makes quality of life (QOL) an important issue in this patient group. This study aimed to develop a supplementary module of the EORTC QLQ-C30 questionnaire to assess TC-s...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576569/ https://www.ncbi.nlm.nih.gov/pubmed/22407356 http://dx.doi.org/10.1007/s11136-012-0147-1 |
_version_ | 1782259868912058368 |
---|---|
author | Holzner, Bernhard Efficace, Fabio Basso, Umberto Johnson, Colin D. Aaronson, Neil K. Arraras, Juan I. Smith, Allan B. Chow, Edward Oberguggenberger, Anne S. Bottomley, Andrew Steiner, Hannes Incrocci, Luca Giesinger, Johannes M. |
author_facet | Holzner, Bernhard Efficace, Fabio Basso, Umberto Johnson, Colin D. Aaronson, Neil K. Arraras, Juan I. Smith, Allan B. Chow, Edward Oberguggenberger, Anne S. Bottomley, Andrew Steiner, Hannes Incrocci, Luca Giesinger, Johannes M. |
author_sort | Holzner, Bernhard |
collection | PubMed |
description | OBJECTIVE: Testicular cancer (TC) is the most common cancer in young men, and its incidence is increasing. The low mortality rate makes quality of life (QOL) an important issue in this patient group. This study aimed to develop a supplementary module of the EORTC QLQ-C30 questionnaire to assess TC-specific aspects of QOL. METHODS: Questionnaire development was conducted according to guidelines from the EORTC Quality of Life Group. Phase I comprised generation of QOL issues relevant to TC patients through a literature search and interviews with patients and experts. Phase II included operationalization and assessment of item relevance. In phase III, items were pre-tested in a cross-cultural sample to assess issues such as understandability and intrusiveness of items. RESULTS: In phase I and II, an initial list of 69 QOL issues possibly relevant to TC patients was refined through patient and expert interviews. The remaining 37 issues were operationalized into items and assessed for relevance and priority in an expert sample (n = 28) and a patient sample (n = 62) from Austria, Canada and the Netherlands. After revision of the item list, 26 items were considered eligible for pre-testing in phase III, in which 156 patients from Australia, Austria, Italy and Spain participated. All items passed criteria for pre-testing, thus forming the new EORTC QLQ-TC26. CONCLUSION: The newly developed EORTC QLQ-TC26 is now available in several languages to assess QOL in TC patients receiving treatment and in TC survivors. Phase IV of questionnaire development will comprise international field testing, including extensive analysis of psychometric characteristics of the EORTC QLQ-TC26. |
format | Online Article Text |
id | pubmed-3576569 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Springer Netherlands |
record_format | MEDLINE/PubMed |
spelling | pubmed-35765692013-02-21 Cross-cultural development of an EORTC questionnaire to assess health-related quality of life in patients with testicular cancer: the EORTC QLQ-TC26 Holzner, Bernhard Efficace, Fabio Basso, Umberto Johnson, Colin D. Aaronson, Neil K. Arraras, Juan I. Smith, Allan B. Chow, Edward Oberguggenberger, Anne S. Bottomley, Andrew Steiner, Hannes Incrocci, Luca Giesinger, Johannes M. Qual Life Res Article OBJECTIVE: Testicular cancer (TC) is the most common cancer in young men, and its incidence is increasing. The low mortality rate makes quality of life (QOL) an important issue in this patient group. This study aimed to develop a supplementary module of the EORTC QLQ-C30 questionnaire to assess TC-specific aspects of QOL. METHODS: Questionnaire development was conducted according to guidelines from the EORTC Quality of Life Group. Phase I comprised generation of QOL issues relevant to TC patients through a literature search and interviews with patients and experts. Phase II included operationalization and assessment of item relevance. In phase III, items were pre-tested in a cross-cultural sample to assess issues such as understandability and intrusiveness of items. RESULTS: In phase I and II, an initial list of 69 QOL issues possibly relevant to TC patients was refined through patient and expert interviews. The remaining 37 issues were operationalized into items and assessed for relevance and priority in an expert sample (n = 28) and a patient sample (n = 62) from Austria, Canada and the Netherlands. After revision of the item list, 26 items were considered eligible for pre-testing in phase III, in which 156 patients from Australia, Austria, Italy and Spain participated. All items passed criteria for pre-testing, thus forming the new EORTC QLQ-TC26. CONCLUSION: The newly developed EORTC QLQ-TC26 is now available in several languages to assess QOL in TC patients receiving treatment and in TC survivors. Phase IV of questionnaire development will comprise international field testing, including extensive analysis of psychometric characteristics of the EORTC QLQ-TC26. Springer Netherlands 2012-03-10 2013 /pmc/articles/PMC3576569/ /pubmed/22407356 http://dx.doi.org/10.1007/s11136-012-0147-1 Text en © The Author(s) 2012 https://creativecommons.org/licenses/by/4.0/ This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited. |
spellingShingle | Article Holzner, Bernhard Efficace, Fabio Basso, Umberto Johnson, Colin D. Aaronson, Neil K. Arraras, Juan I. Smith, Allan B. Chow, Edward Oberguggenberger, Anne S. Bottomley, Andrew Steiner, Hannes Incrocci, Luca Giesinger, Johannes M. Cross-cultural development of an EORTC questionnaire to assess health-related quality of life in patients with testicular cancer: the EORTC QLQ-TC26 |
title | Cross-cultural development of an EORTC questionnaire to assess health-related quality of life in patients with testicular cancer: the EORTC QLQ-TC26 |
title_full | Cross-cultural development of an EORTC questionnaire to assess health-related quality of life in patients with testicular cancer: the EORTC QLQ-TC26 |
title_fullStr | Cross-cultural development of an EORTC questionnaire to assess health-related quality of life in patients with testicular cancer: the EORTC QLQ-TC26 |
title_full_unstemmed | Cross-cultural development of an EORTC questionnaire to assess health-related quality of life in patients with testicular cancer: the EORTC QLQ-TC26 |
title_short | Cross-cultural development of an EORTC questionnaire to assess health-related quality of life in patients with testicular cancer: the EORTC QLQ-TC26 |
title_sort | cross-cultural development of an eortc questionnaire to assess health-related quality of life in patients with testicular cancer: the eortc qlq-tc26 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576569/ https://www.ncbi.nlm.nih.gov/pubmed/22407356 http://dx.doi.org/10.1007/s11136-012-0147-1 |
work_keys_str_mv | AT holznerbernhard crossculturaldevelopmentofaneortcquestionnairetoassesshealthrelatedqualityoflifeinpatientswithtesticularcancertheeortcqlqtc26 AT efficacefabio crossculturaldevelopmentofaneortcquestionnairetoassesshealthrelatedqualityoflifeinpatientswithtesticularcancertheeortcqlqtc26 AT bassoumberto crossculturaldevelopmentofaneortcquestionnairetoassesshealthrelatedqualityoflifeinpatientswithtesticularcancertheeortcqlqtc26 AT johnsoncolind crossculturaldevelopmentofaneortcquestionnairetoassesshealthrelatedqualityoflifeinpatientswithtesticularcancertheeortcqlqtc26 AT aaronsonneilk crossculturaldevelopmentofaneortcquestionnairetoassesshealthrelatedqualityoflifeinpatientswithtesticularcancertheeortcqlqtc26 AT arrarasjuani crossculturaldevelopmentofaneortcquestionnairetoassesshealthrelatedqualityoflifeinpatientswithtesticularcancertheeortcqlqtc26 AT smithallanb crossculturaldevelopmentofaneortcquestionnairetoassesshealthrelatedqualityoflifeinpatientswithtesticularcancertheeortcqlqtc26 AT chowedward crossculturaldevelopmentofaneortcquestionnairetoassesshealthrelatedqualityoflifeinpatientswithtesticularcancertheeortcqlqtc26 AT oberguggenbergerannes crossculturaldevelopmentofaneortcquestionnairetoassesshealthrelatedqualityoflifeinpatientswithtesticularcancertheeortcqlqtc26 AT bottomleyandrew crossculturaldevelopmentofaneortcquestionnairetoassesshealthrelatedqualityoflifeinpatientswithtesticularcancertheeortcqlqtc26 AT steinerhannes crossculturaldevelopmentofaneortcquestionnairetoassesshealthrelatedqualityoflifeinpatientswithtesticularcancertheeortcqlqtc26 AT incrocciluca crossculturaldevelopmentofaneortcquestionnairetoassesshealthrelatedqualityoflifeinpatientswithtesticularcancertheeortcqlqtc26 AT giesingerjohannesm crossculturaldevelopmentofaneortcquestionnairetoassesshealthrelatedqualityoflifeinpatientswithtesticularcancertheeortcqlqtc26 |